Media Centre

On this page you'll find media statements issued by MSWA containing information about events, fundraising, investment in research, services and facilities and corporate news. Media outlets are welcome to follow up with us for further information.

Tony Millar - Chief Marketing Officer
M 0456 415 832

8 May 2024
MSWA announces the commencement of construction of the long-awaited Montario Quarter. This initiative underscores MSWA's unwavering commitment to providing top-tier support for individuals neurological conditions and spinal cord injuries across Western Australia. Read more >

29 November 2023
A world-leading clinical trial will seek to reverse neurological damage caused by primary progressive multiple sclerosis (PPMS) in Australians living with the debilitating condition, in an announcement made today at the MS Australia Progress in Research Conference in Perth. Read more >

5 July 2023
New clues found in hunt for MS cure. MSWA's Chief Marketing Officer to interview Dr. Fabis-Pedrini on the revolutionary MS research breakthrough. Read more >

2 December 2022
MSWA's 2022-2023 commitment to neurological research. Read more >

21 September 2021
New MSWA CEO appointed. Read more >

20 July 2021
MSWA Commitment to Research, 2021 Announcement. Read more >

13 May 2021
CEO Marcus Stafford Announces Retirement. Read more >

8 March 2021
MSWA is WA’s leading contributor to neurological research. Read more >

2 March 2021
MSWA and ECU research funding partnership: New motion-sensing technology set to make waves for people living with neurological conditions. Read more >

For media statements from 2016 - 2020, click here.